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(57) ABSTRACT
A method is provided for preparing shells, concentric shells 
or porous, homogenous gels from alkali borate glass par­
ticles at low temperatures (i.e. room temperature or less than 
above 100° C.). The alkali borate glass particles contain one 
or more cations such as aluminum which react with an 
aqueous solution containing an anion such as hydroxide to 
form an aqueous insoluble material having a solubility limit 
of less than about 0.01 wt. percent. TTie resulting shells or 
gels may be used in many different applications such as a 
filler in resins, as filters, precursors for nano-sized powders, 
as thin surface films or catalyst support media. The resulting 
shells or gels may also have a chemotherapeutic drug added 
thereto, following which the resulting product is adminis­
tered to a mammal and the insoluble material is dissolved 
form the product in vivo through administration of chelating 
agent.
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METHOD FOR PREPARING POROUS 
SHELLS OR GELS FROM GLASS 
PARTICLES
BACKGROUND OF THE INVENTION
This invention relates to a method for preparing a shell or 
porous gel from glass particles and, more particularly, to 
such a method in which glass particles are reacted, non- 
uniformly corroded or partially dissolved to convert solid 
glass particles into a product composed of shells, concentric 
shells or a porous, homogeneous gel which can be used in 
various applications.
Hollow glass microspheres have been produced in large 
quantities since the 1930’s (C. D. Hendricks, “Glass 
Spheres”, in Ceramics and Glasses, Vol. 4 Engineered 
Materials Handbook, 418-422, ASM International, USA 
(1991); and Neusy U.S. Pat. No. 4,487,620). Traditionally 
hollow glass microspheres have been processed by mixing 
glass forming raw materials (i.e. soda, lime and silica) with 
an organic material such as urea. These materials are mixed 
into a slurry, which is subsequently dried into a cake and 
crushed into small (<200 /im) particles. The particles are 
then introduced into a high temperature flame where the 
glass forming materials melt, and the gas released from 
decomposition of the organic material forms hollow glass 
microspheres. Many refinements of this general technique 
have been used to make the majority of hollow microspheres 
which are now commercially available. The main disadvan­
tage of this method is that flame temperatures exceeding 
1200° C. must be used to produce the hollow microspheres. 
The hollow microspheres made using this “burn out” 
method are primarily used as fillers in light weight polymers, 
high temperature insulation and as fillers in paints (C. D. 
Hendricks, supra; L. H. Smiley, “Hollow Microspheres: 
More Than Just Fillers, Mech. Eng. Feb. 27-30 (1986); and 
R. H. Wehrenberg, “Shedding Pounds in Plastics: Micro­
spheres are Moving”, Mech. Eng. Oct. 58-63 (1978)).
Hollow glass microspheres can also be produced using 
sol-gel processing (R. L. Downs et al., “Hollow Glass 
Microspheres by Sol-Gel Technology” in Sol-Gel Technol­
ogy for Thin Films, Fibers, Preforms, Electronics and Spe­
cialty Shapes, Ed. L. Klein, 330-380, Noyes Publications, 
NJ, (1988); L. C. Klein, “Sol-Gel Process” in Ceramics and 
Glasses, Vol. 4 Engineered Materials Handbook, 209-214, 
ASM International, USA(1991); and R. D. Shoup, “Sol-Gel 
Processes”, in Ceramics and Glasses, Vol. 4 Engineered 
Materials Handbook, 445-452, ASM International, USA 
(1991)). A sol is first prepared by mixing metal alkoxides, 
such as tetraethylorthosilicate (TEOS), with water and etha­
nol. This sol is then heated and acid catalyzed to form a 
silicate gel. The gel is dried and crushed into particles which 
are spheroidized in a high temperature (>1200° C.) flame. 
While in the flame, the gel particles melt and decomposing 
organic groups release gas to form hollow glass micro­
spheres. This technique is used to prepare hollow glass 
microspheres with very high purity and uniform wall thick­
nesses. The sol gel processing of hollow glass microspheres 
is very costly due to the high cost of the metal alkoxides used 
as raw materials. Sol gel processing also requires high 
temperatures and multiple processing steps which must be 
closely monitored. Thus, this technique is only used for very 
specialized applications such as the formation of hollow 
microspheres which are impregnated with deuterium and 
tritium for use in laser fusion experiments (R. H. 
Wehrenberg, supra).
There is a continuing need for improved processes for 
preparing a shell or porous gel from glass particles, particu­
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larly for processes which can be carried out at low tempera­
tures (<100° C.) and which can produce hollow, porous 
microspheres of many different chemical compositions.
SUMMARY OF THE INVENTION
Among the several objects of the invention may be noted 
the provision of a method for preparing from glass particles 
a product composed of a shell filled with colloidal particles 
or gel, concentric shells, or a porous, homogenous gel; the 
provision of such a method by which porous/hollow shells 
may be produced at or near room temperature; the provision 
of a method of the type described which advantageously 
produces a porous product which may be filled with various 
types of liquids and gases; the provision of such a method 
which allows hollow/porous products of many different 
chemical compositions to be prepared; and the provision of 
a method for administering a chemotherapeutic drug which 
permits porous microspheres formed by glass particle/ 
solution reactions to be dissolved with a chelating agent. 
Other objects and features will be in part apparent and in part 
pointed out hereinafter.
Briefly, the present invention in one aspect is directed to 
a method for preparing a shell or porous gel from glass 
particles which involves the steps of:
(a) forming particles of an alkali borate glass composition 
containing one or more cations which react with an 
aqueous solution containing an anion reactive with the 
cation to form an aqueous insoluble material having a 
solubility limit of less than about 0.01 wt. percent;
(b) immersing the glass composition particles in the 
aforementioned aqueous solution so that the particles 
react and form the insoluble material which is essen­
tially the same size as the as-made particles with the 
alkali and borate dissolving from the glass particles; 
and
(c) allowing the chemical reaction to continue until the 
alkali and boron are substantially completely dissolved 
from the glass particles and the resulting product is 
composed of a shell filled with colloidal particles or 
gel, concentric shells or a porous, homogeneous gel, 
the product being nonradioactive and not adapted for 
neutron irradiation.
In another aspect, the invention is directed to a method for 
administering a chemotherapeutic drug which involves the 
three above-noted steps and the additional steps of adding a 
chemotherapeutic drug to the above-noted resulting product 
and administering the then resulting product to a mammal, 
and thereafter dissolving the insoluble material from this 
product in vivo through the administration of a chelating 
agent. Another additional step may involve heat treating the 
above-noted resulting product so as to improve its mechani­
cal strength or to control its porosity/permeability for the 
purpose of controlling the rate at which a drug is released or 
the product may be filled with a drug.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows optical micrographs of pure Li20 3—B20 3 
glass microspheres immersed in a phosphate buffered saline 
(PBS) solution at 37° C. for 0, 5, 10, 15, 20 and 25 minutes 
with the microspheres progressively shrinking in size as they 
uniformly dissolve in the solution;
FIG. 2 shows optical micrographs of three Dy20 3— 
Li20 —B20 3 glass microspheres immersed in PBS solution 
at 37° C. for 0, 15, 30, 45, 60 and 75 minutes. A spherical 
















minutes and the core becomes progressively smaller until it 
is no longer detectable after 75 minutes;
FIG. 3 is a schematic model of the chemical reaction 
occurring between a borate glass and a solution, such as 
PBS, where an insoluble material is formed as a series of 
concentric shells;
FIG. 4 is a cross-sectional view of a Dy20 3—Li20 — 
B20 3 glass microsphere which has been immersed in PBS 
solution for 24 hours at 37° C. and then impregnated with 
polymethyl methacrylate. The white region is composed of 
an amorphous, porous dysprosium phosphate gel;
FIG. 5 is a high magnification SEM micrograph showing 
the smooth, external surface of an “as-made” Dy20 3— 
Li20 —B20 3 glass microsphere;
FIG. 6 is a high magnification SEM micrograph showing 
the surface of a Dy20 3—Li20 —B20 3 glass microsphere 
which was immersed in PBS solution for 24 hours at 37° C.;
FIG. 7 is a backscatter SEM image of a cross-sectioned 
Dy20 3—Li20 —B20 3 microsphere which initially con­
tained 3 wt. % Dy20 3, and was fully reacted with PBS 
solution at 37° C.;
FIG. 8 is a backscatter SEM image of a cross-sectioned 
Dy20 3—Li20 —B20 3 glass microsphere which initially 
contained 10 wt. % Dy20 3 and was fully reacted with PBS 
solution at 37° C.;
FIG. 9 is a backscatter SEM image of a cross-sectioned 
Dy20 3—Li20 —B20 3 glass microsphere which initially 
contained 30 wt. % Dy20 3, and was fully reacted with PBS 
solution at 37° C.;
FIG. 10 shows optical micrographs of Dy20 3—Li20 — 
B20 3 glass microspheres and borosilicate glass particles 
immersed in PBS solution at 37° C. (A, B and C). At 1 hr:42 
minutes, 25 fil of 0.75M EDTA solution was added and 
complete chelation (dissolution) of the spherical dysprosium 
phase was observed at 2 hr:05 minutes (E and F). The 
bottom micrographs D, E and F show the disappearance of 
the shells after the addition of EDTA, but the angular, 
irregular borosilicate glass particles remain unaffected;
FIG. 11 is a backscatter SEM micrograph of Dy20 3— 
Li20 —B20 3 microspheres which have reacted in the rat to 
form dysprosium phosphate and borosilicate glass particles 
(irregular shape) after two weeks in a rat knee. The rat knee 
did not receive an EDTA injection so the insoluble dyspro­
sium phosphate microspheres are still present along with the 
insoluble borosilicate particles; and
FIG. 12 is a backscatter SEM micrograph of irregular 
borosilicate glass particles remaining in a rat knee after the 
addition of EDTA. Note that all microspheres have been 
completely dissolved by the EDTA and none are visually 
detectable.
DESCRIPTION OF THE PREFERRED 
EMBODIMENTS
In accordance with the present invention, it has now been 
found that hollow/porous shells may be produced from glass 
particles by a method which can be carried out at or near 
room temperature. The novel method of the invention 
employs alkali borate glasses of an appropriate composition 
which are first crushed into particles or made into spheres of 
the desired size. Pure alkali borate glasses have very poor 
chemical durability and will completely dissolve when 
immersed in aqueous solutions as shown in FIG. 1. In 
accordance with the invention, the alkali borate glass com­
positions utilized contain a cation such as a rare earth 
(Dy3+), calcium or iron (Ca2+or Fe3+) which react with an
3
aqueous solution containing an anion such as hydroxide or 
phosphate to form an aqueous insoluble material having a 
solubility limit of less than about 0.01 wt. %. When the 
alkali borate glass composition particles are immersed in an 
aqueous solution, such as a body fluid for example, non- 
uniform reaction, corrosion or dissolution of the glass par­
ticles occurs and the reaction between the cation in the glass 
composition and the anion in the aqueous solution forms an 
insoluble material which is essentially the same size and 
shape as the “as-made” particles, see FIG. 2.
FIG. 3 shows a schematic representation of the mecha­
nisms which occur during the non-uniform reaction of the 
alkali borate glass compositions. As shown, during the 
chemical reaction, the alkali and boron ions dissolve from 
the glass particles or microspheres and go into solution. The 
insoluble cations in the glass (e.g. Ca2+, Dy3+) react with 
OH- and/or PO4- anions present in the aqueous solution 
(e.g. saline solution or body fluid) to form an insoluble 
oxide, hydroxide or phosphate gel on or around the micro­
spheres or glass particles. In one aspect of the invention, this 
insoluble gel initially forms at the original surface of the 
“as-made” particles or microspheres. Thus, the gel remains 
the same shape and size as the “as-made” particles or 
microspheres. As the non-uniform reaction progresses 
inward, toward the center of the microsphere, the dissolving 
core can separate from the outer shell depending upon the 
content of the reacting cation in the glass and the rate at 
which the glass reacts with the solution. As this core 
detachment occurs, another shell can begin to form around 
the separated core as it continues to react non-uniformly. 
These shell formation and disconnection or detachment 
steps continue to occur until the inner core of “as-made” 
glass has completely reacted. The resulting reaction product 
is generally composed of concentric shells of an amorphous, 
or crystalline highly porous solid.
By varying the amount of insoluble cation present in the 
glass composition used for the glass/aqueous solution 
reaction, one can obtain resulting products having one of 
three different microstructures as shown in FIGS. 7-9. The 
microstructures shown in FIGS. 7-9 are based primarily 
upon SEM investigations performed on dysprosium lithium 
borate (Dy20 3—Li02—B20 3) glass microspheres which 
were reacted in phosphate buffered saline (PBS) solution. 
FIG. 7 shows the first microstructure characterized by a rigid 
dysprosium phosphate shell filled with colloidal particles of 
the same composition obtained by reacting a glass compo­
sition containing 3 wt. % Dy20 3 with PBS solution at 37° C.
FIG. 8 shows the second type of microstructure previ­
ously discussed above which can be described as a concen­
tric shell microstructure formed by reacting an “as-made” 
dysprosium lithium borate glass containing 10 wt. % Dy20 3 
with PBS solution at 37° C.
FIG. 9 shows the third type of microstructure formed by 
the glass/aqueous solution reaction depicted in FIG. 3 and 
can be described as a porous, homogenous gel formed by 
reacting an “as-made” dysprosium lithium borate glass 
containing 30 wt. % Dy20 3 with PBS solution at 37° C. 
Because the glass contained such a high amount of insoluble 
dysprosium, a continuous gel formed during the glass/ 
aqueous solution reaction.
In the practice of the invention, the alkali borate glass 
employed may contain lithium, sodium, potassium, 
rubidium or cesium individually or a mixture of these 
alkalis. The cation contained in the alkali borate glass 
composition may be an alkaline earth metal cation such as 
















cation such as chromium or zirconium (i.e. Cr3+ and Zr4+), 
rare earth metal cation such as dysprosium, samarium, 
yttrium or holmium (i.e. Dy3+, Sm3+, Y3+ and Ho3+) or an 
aluminum (Al3+) or iron (Fe3+) cation. The anion or ligand 
contained in the aqueous solution reacted with the glass 
composition may be hydroxide, oxygen, phosphate, sulfate, 
chromate, carbonate or other anion and hydrated forms 
thereof which will react with the cation in the glass com­
position to form an aqueous insoluble material having a 
solubility limit of less than about 0.01 wt. %. The insoluble 
material may be an oxide, hydroxide, phosphate, sulfate, 
chromate, carbonate or hydrated form thereof. For example, 
when the aqueous solution is a body fluid containing phos­
phate anions, the insoluble material formed by chemical 
reaction of these anions with cations such as calcium or 
aluminum would be calcium or aluminum phosphate.
In the three microstructures of the products produced 
through the method of the present invention, the micro­
graphs of FIGS. 7-9 are low magnification and do not show 
the existence of nanometer-size porosity which the dyspro­
sium phosphate insoluble material in each microstructure 
possesses. Such porosity is advantageous in the use of such 
materials as filtration or drug delivery devices where poros­
ity is essential.
The method of the present invention through the achieve­
ment of non-uniform reaction of alkali borate glass compo­
sitions provides a number of advantages. An important and 
practical advantage is that the method may be performed at 
low temperatures (i.e. room temperature or <100° C.). While 
the microspheres employed for aqueous reaction are pro­
duced using a high temperature flame, the method of the 
invention for preparing the porous/hollow shells is per­
formed at or near room temperature. Room temperature 
processing allows porous/hollow shells to be produced and 
then filled with substances which will not tolerate high 
temperatures. These microspheres or glass compositions can 
be reacted as described and then filled with drug solutions or 
organic materials useful for treating ailments and diseases 
within the body. Thus, low temperature processing of 
porous/hollow shells constitutes a major advantage over the 
currently available high temperature methods described 
above when the glass compositions are intended to be filled 
with substances that cannot withstand temperatures above 
about 100° C.
Another advantage of the method of the invention is that 
it can be used to produce hollow microspheres which are 
also porous and hence easily tillable with various types of 
liquids, solids and gases. Microspheres produced by the 
burn-out and sol gel techniques previously described do not 
have porous walls and are difficult to fill with any substance.
Still another major advantage of the novel method of the 
invention is that many different chemical compositions of 
hollow microspheres can readily be produced. The compo­
sition of the porous/hollow shells is determined by whatever 
insoluble cations are incorporated into the “as-made” glass 
and by the anions in the solution. As mentioned above, such 
cations may be rare earth metal cations, alkaline earth metal 
cations, transition metal cations (like iron), aluminum or 
actinide cations incorporated into alkali borate glasses to 
produce hollow/porous microspheres. Thus, the method of 
the invention provides a major advantage over the high 
temperature burn-out and sol gel methods since the latter 
only allow hollow microspheres to be formed from glass 
forming constituents. With these two methods shells are 
only oxides, but with the present invention shells can be a 
phosphate, hydroxide, sulfate, chromate, etc. compound.
The three known microstructures which can be produced 
by the method of the present invention are shown as a shell
5
filled with colloidal particles or gel (FIG. 7), concentric 
shells (FIG. 8) or a porous, homogeneous gel (FIG. 9), these 
microstructures being obtained by varying the amount of 
insoluble cation in the “as-made” glass composition utilized 
for the glass/aqueous solution reaction. The products of the 
method of the invention may be in the form of microspheres, 
irregularly shaped particles or an assemblage of micro­
spheres or irregularly shaped particles and may be filled with 
a liquid, gas or solid material. Particles ranging in size from 
about 5 microns to larger than 1,000 microns can be con­
verted into porous gels. In addition, the product produced 
through the practice of the invention may be further heat 
treated at an elevated temperature to modify the properties 
(e.g. strength, porosity, permeability of the shell/gel).
The products of the method of the invention may be found 
useful in many different applications. Thus, the resulting 
heat treated product may be used as a filler in resins, 
polymers or metals to reduce weight and enhance strength or 
in paints to vary the rheology of the paint. Biodegradable, 
hollow/porous shells produced through the invention may be 
impregnated with chemotherapeutic drugs, such as 
methotrexate, doxorubicin, alpha, beta and gamma 
interferons, alpha and beta tumor necrosis factors, antibiot­
ics or other known chemotherapeutic agents, and injected 
into malignant tissue to slowly deliver long term doses of 
medication. Porous/hollow shells produced by the novel 
method of the invention and composed of refractory oxides, 
such as aluminum oxide (A120 3), could be sintered to form 
high purity, high temperature insulation. Porous/hollow 
shells containing calcium and phosphorous could be used in 
vivo to accelerate the growth of bone within the body or to 
function as bone repair agents. Other uses for the products 
of the invention include use as catalyst supports where 
refractoriness and high porosity would be beneficial and as 
laser fusion targets, the porous/hollow shells being filled 
with deuterium and tritium and used as targets for laser 
fusion. Still further, the porous shells/gels produced by the 
method of the invention may be used as filters, precursors 
for nano sized powders, as thin surface films or to remove 
hazardous species such as chromates, arsenates, uranates 
and the like from solution. Another application for the 
products of the method of the invention is for catalyst 
support media, i.e. the porous shells can be impregnated 
internally or coated on their surface with catalytic materials. 
Thus, the porous, hollow shells may be impregnated 
throughout their thickness with metals such as platinum, 
palladium or the like having catalytic properties. In each 
instance, the product of the invention is nonradio active and 
not adapted for neutron irradiation.
In another aspect of the invention, a method is provided 
for administering a chemotherapeutic drug to a mammal 
which involves the steps described above for forming a 
primary product of the invention, followed by the steps of 
adding a chemotherapeutic drug to the product, administer­
ing the resulting product to a mammal and thereafter dis­
solving the insoluble material from the product in vivo 
through the administration of a chelating agent. As previ­
ously noted, the primary product of the method of the 
invention is a porous material which is insoluble in solutions 
with a near-neutral pFl such as most body fluids. Such a 
porous product is ideally suited for use in drug delivery since 
the high concentration of nano-sized porosity allows the 
microspheres or gels to carry a relatively large amount of a 
drug to a treatment area within the body for slow release of 
the drug. For example, porous calcium phosphate micro­
spheres made in accordance with the method of the inven­

















delivery because they are chemically similar to hard tissue 
in the body and biocompatible. Such porous microspheres 
can be produced by reacting alkali-calcium-borate glass 
microspheres with phosphate buffered saline (PBS) solution 
and the resulting porous microspheres may be filled with a 
drug, such as an antibacterial agent, and injected into the 
body to treat an infected area. While such porous micro­
spheres are thus highly suitable for drug delivery in this 
manner, a potential complication lies in the removal of these 
microspheres from the body after drug delivery therefrom 
has been completed.
In accordance with another aspect of the present 
invention, it has been found that hollow/porous micro­
spheres may be removed from a living organism after drug 
delivery therefrom has been accomplished through the 
administration of a chelating agent. For this purpose, various 
chelating agents known in the art may be employed 
including, but not limited to, ethylenediaminetetraacetic 
acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), 
nitrilotriacetic acid (NTA), trimethylenediaminetetraacetic 
acid, trie thy lenetetraaminehexaace tic acid, 1, 4, 7, 10 tet- 
raacetic acid and hydroxyethylethylenediaminetriacetic acid 
(HEDTA). It will be understood that other chelating agents 
known to the art may also be employed in the practice of this 
method for dissolving or chelating the insoluble material 
from the microspheres after drug delivery has been 
achieved.
As shown by the experimental results set forth hereinafter 
and by reference to FIGS. 10-12, the chelating agent eth­
ylenediaminetetraacetic acid (EDTA) was effective in dis­
solving porous dysprosium and calcium phosphate micro­
spheres produced by alkali borate glass/aqueous solution 
reaction in vitro and dissolving dysprosium phosphate in 
vivo. Thus, in the in vitro chelation tests, calcium lithium 
borate or dysprosium lithium borate glass microspheres 
were placed in PBS solution at 37° C. and allowed to 
completely react to form calcium phosphate or dysprosium 
phosphate microspheres. In the in vivo tests, the knees of 
several Sprague Dawley rats were injected with equal 
weights of dysprosium lithium borate microspheres and a 
borosilicate glass control. In both the in vitro and in vivo 
tests, the administration of ethylenediaminetetraacetic acid 
was effective in dissolving or removing the calcium or 
dysprosium phosphate materials.
The following examples illustrate the practice of the 
invention.
EXAMPLE 1
Glass microspheres were prepared by first mixing 45 g of 
a lithium borate glass frit (12.5 wt. % Li20 , 87.5 wt. % 
B20 3) with 5 g of the metal oxides Dy20 3, Sm20 3, Y20 3, 
H o20 3, A120 3, Fe20 3 and CaO, respectively. The mixed 
powders were then placed in a platinum crucible, melted at 
1100° C. for 15 minutes, and then cast onto a stainless steel 
plate. The quenched glass was crushed by mortar and pestle 
and introduced into a propane air flame to form micro­
spheres 5 to 15 fim in diameter. Visual inspection of the 
microspheres during aqueous corrosion was facilitated by 
their spherical shape and small size.
As shown in FIG. 1, pure lithium borate (Li20 —B20 3) 
glass microspheres chemically reacted in a uniform manner 
and become progressively smaller when immersed in phos­
phate buffered saline solution (PBS) having the following 
composition at 37° C.:
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However, each of the glass compositions with 10 wt. % of 
the metal oxides Dy20 3, Sm20 3 , Y20 3, Ho20 3, A120 3, Fe2 
0 3 and CaO incorporated into a lithium borate glass as 
described above reacted non-uniformly when immersed in 
PBS solution at 37° C. FIG. 2 shows real time video 
microscopy (RTVM) optical micrographs of three Dy20 3— 
Li20 3—B20 3 glass microspheres chemically reacting non- 
uniformly in PBS solution at times ranging from 0 to 75 
minutes. As shown, a spherical core of “as-made” glass is 
clearly visible after 15 minutes. Rather than dissolving 
uniformly and becoming progressively smaller, a shell forms 
at the original surface of the glass microsphere and a core of 
“as made” glass continues to react until it has completely 
reacted leaving a spherical corrosion product behind.
A reaction rate was calculated for each glass composition 
prepared as described above by measuring the shrinkage in 
the core radius as a function of time from optical micro­
graphs obtained using RTVM. The non-uniform reaction 
rates calculated for each glass immersed in PBS solution at 
37° C. are given in the following table and vary between 6 
and 11 /rm/h:
Metal Oxide Incorporated 





y 2o 3 6
Ho20 3 11
a i2o 3 11
Fe20 3 10
CaO 7
*10 wt. % metal oxide added to a 11.25 wt. % Li20 ,  78.75 wt. % B20 3 
glass
**Rate at which the core of “as-made” glass radially shrinks during non- 
uniform reaction.
These reaction rates are high enough to completely react 
15/rm microspheres in PBS solution at 37° C. within 2 hours.
The mechanisms which occur during non-uniform reac­
tion are shown in FIG. 3. Non-uniform reaction is initiated 
at the original surface of each glass microsphere, as lithium 
and boron dissolve into the surrounding solution. The 
insoluble cations in the glass (i.e. Dy3+) are not completely 
dissolved into solution. Rather, these cations react with OH- 
and/or P 043- anions present in the aqueous solution adjacent 
to the reacting glass to form an insoluble, amorphous, 
gel-like shell at the surface of each glass microsphere. As 
time elapses, continued alkali and boron dissolution can 
cause the core of “as-made” glass to shrink, and separate 
from the outer shell. If core separation occurs, another shell 
will begin to form around the detached glass core as the 
insoluble cations again react with ions in the aqueous 
solution. These core separation and shell formation steps 
continue to occur until the core of “as-made” glass has 
completely reacted.
This non-uniform reaction generally results in the forma­
tion of porous/hollow shells which remain the same size and 















spheres are generally composed of concentric shells of a 
porous hydroxide or phosphate gel. If, for example, a 
Dy20 3—Li20 —B20 3 glass microsphere is reacted in PBS 
solution, the reacted microspheres will be composed of 
concentric shells of an amorphous dysprosium phosphate 
gel. If there is no phosphorous present in the solution (i.e. 
saline solution), the reacted microspheres will be composed 
of concentric shells of an amorphous dysprosium hydroxide 
gel.
EXAMPLE 2
Large (100 to 200 fim in diameter) Dy20 3—Li20 —B20 3 
microspheres were reacted in PBS solution at 37° C. to 
investigate the internal microstructure of microspheres 
which were non-uniformly reacted. The large Dy20 3— 
Li20 —B20 3 glass microspheres were immersed in PBS 
solution for 24 hours at 37° C., dehydrated with ethanol and 
then impregnated with poly-methyl methacrylate. These 
polymer-impregnated microspheres were then cross- 
sectioned with a diamond saw, polished and examined by 
SEM. FIG. 4 shows the cross section of a Dy20 3—Li20 — 
B20 3 microsphere after non-uniform reaction in PBS solu­
tion. The concentric shells of dysprosium phosphate are 
easily seen in FIG. 4. Although a concentric shell micro­
structure is generally produced using this technique, com­
pletely hollow microspheres may be produced by decreasing 
the wt. % of the insoluble metal oxide in the “as-made” 
microspheres, or by reacting the “as-made” microspheres in 
acidic or basic solutions.
Eligh resolution SEM was used to analyze the pore 
structure of the large reacted microspheres. FIGS. 5 and 6 
show high magnification SEM micrographs of “as-made” 
and reacted (PBS) Dy20 3—Li20 —B20 3 glass surfaces, 
respectively. The “as-made” surface is smooth and dense, 
while the reacted surface is porous and rough with pore radii 
approximately 35 nm in diameter. These high resolution 
SEM micrographs establish that the concentric shells formed 
during non-uniform reaction are porous.
EXAMPLE 3
Microspheres 5 to 15 fim in diameter were placed in 
polycarbonate filter packets and allowed to react in PBS 
solution at 37° C. for time intervals ranging from 0.25 to 64 
days. After each time interval, the packets were removed 
from the PBS solution and the weight loss was determined. 
Only Dy20 3—Li20 —B20 3 glasses were analyzed using 
this weight loss technique, and these glasses lost 75% of 
their original weight in less than six hours. After reacting 6 
hours in PBS solution, no further weight loss occurred. 
Thus, reaction in aqueous solutions can be used to convert 
the solid glass microspheres into highly porous shells in 
short periods of time.
EXAMPLE 4
Nitrogen absorption surface area analysis was performed 
on “as-made” microspheres and microspheres which were 
immersed in PBS solution for 24 hours at 37° C. and then air 
dried. The specific surface area (SSA) of Dy20 3—Li20 — 
B20 3 microspheres increased by over 1000 times after being 
immersed in PBS solution at 37° C. for 24 hours. This huge 
increase in SSA provides further proof that the concentric 
shells formed during non-uniform reaction are porous.
EXAMPLE 5
Three known microstructures can be produced by the 
glass/solution reaction method of the present invention.
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These microstructures are obtained by varying the amount of 
insoluble cation in the “as-made” glass used for glass/ 
solution reaction. The microstructures may also be varied by 
varying the amount of anion in the solution. FIGS. 7-9 show 
three microstructures obtained by reacting the respective 
glass with PBS solution, dehydrating the microspheres with 
ethanol, monomer infiltrating with methyl methacrylate 
monomer (MMA) and subsequently polymerizing (PMMA) 
before viewing by backscatter SEM.
The first microstructure shown in FIG. 7 is characterized 
by a rigid dysprosium phosphate shell filled with colloidal 
particles of the same composition. This microstructure was 
obtained by reacting a glass containing 3 wt. % Dy20 3 with 
PBS solution at 37° C. FIG. 7 shows a cross sectional view 
of a reacted dysprosium-lithium borate microsphere which 
initially contained 3 wt. % Dy20 3. There is a 95% weight 
loss associated with the formation of this shell-type micro­
structure.
The second type of microstructure is shown in FIG. 8 and 
can be described as a concentric shell microstructure. This 
microstructure was formed by reacting an “as-made” 
dysprosium-lithium borate glass which contained 10 wt. % 
Dy20 3 with PBS solution. An 80% weight loss is associated 
with the formation of this microstructure from the “as- 
made” glass.
The third microstructure formed by glass/solution reac­
tion is shown in FIG. 9 and can be described as a porous, 
homogeneous gel. The “as-made” dysprosium-lithium 
borate glass used to make this microstructure initially con­
tained 30 wt. % Dy20 3. A continuous porous, homogeneous 
gel formed during glass/solution reaction because the glass 
contained such a high amount of insoluble dysprosium. A 
60% weight loss is associated with the formation of this 
microstructure from the “as-made” glass. While the micro­
structure shown in FIG. 9 appears as though it is composed 
of a solid microsphere, it is actually porous on the 30 to 50 
nm level which is advantageous in the use of these micro­
structure materials as filtration or drug delivery devices 
where porosity would be essential.
EXAMPLE 6
The following i vitro and in vivo chelation experiments 
were performed to determine whether the porous micro­
spheres formed by glass/solution reaction could be dissolved 
with a chelating agent such as ethylenediaminetetraacetic 
acid (EDTA).
The in vitro EDTA chelation tests were performed by 
placing either calcium-lithium borate or dysprosium-lithium 
borate glass microspheres in PBS solution at 37° C. and 
allowing them to completely react to form a calcium phos­
phate or dysprosium phosphate. After porous calcium phos­
phate or dysprosium phosphate microspheres were formed, 
a small amount (25 fil of 0.75M EDTA solution) was added 
to dissolve the particles.
The EDTA chelation was effective in completely dissolv­
ing the hollow calcium and dysprosium phosphate materials 
in vitro. FIG. 10 shows micrographs from an in vitro EDTA 
chelation test performed on dysprosium-lithium borate glass 
microspheres. The top three micrographs show the 
dysprosium-lithium borate glass microspheres reacting with 
the PBS solution to form shells of a porous dysprosium 
phosphate. Note the appearance of a reaction layer in 
micrograph 10B which moves inward (10C) until the entire 
sphere has reacted (10D). The irregularly shaped particles in 
each micrograph of FIG. 10 are borosilicate glass particles 
















dissolved by EDTA. These particles were added to act as a 
comparative control material. EDTA was added prior to the 
fourth micrograph (10D) (1 hr., 42 minutes into the test), and 
the microspheres were completely dissolved within 25 min­
utes (FIG. 10F). Thus, FIGS. 10D-10F show the disappear­
ance of the dysprosium phosphate shells after the EDTA was 
added at 1 hr., 42 minutes, but the irregularly-shaped boro- 
silicate glass particles which do not react with EDTA remain 
unaffected after the addition of EDTA.
Similar results were obtained with calcium-lithium borate 
microspheres thus demonstrating that EDTA is effective in 
dissolving the porous materials produced by glass/solution 
reaction in vitro.
For an in vivo experiment, the knees of several Sprague 
Dawley rats were injected with approximately 1.0 mg of an 
equivolumetric ratio of “as-made” dysprosium-lithium 
borate microspheres and irregularly-shaped borosilicate 
glass particles. The borosilicate particles were used as a 
control, since they are unaffected by EDTA. One day after 
injection, half of the knees were injected with 25 fil of 0.75M 
EDTA solution, while the other half were not injected with 
EDTA. All rats were then sacrificed approximately two 
weeks after receiving the initial injection of microspheres 
and borosilicate particles.. All knees were excised, 
dehydrated, monomer infiltrated with methyl methacrylate 
monomer (MMA) and polymerized (PMMA).
The polymerized knees were sectioned and examined by 
SEM to determine whether EDTA was effective in removing 
the microspheres from the knees. FIG. 11 is a micrograph 
showing the knee of a rat which was injected with a mixture 
of “as-made” glass microspheres and borosilicate glass 
particles without receiving an EDTA injection. During the 
two week period the “as-made” micropheres were in the rat, 
they reacted with the body fluids to form insoluble dyspro­
sium phosphate. Since the knee was not injected with EDTA, 
the insoluble reacted microspheres are still present along 
with the insoluble borosilicate glass particles. In contrast, 
FIG. 12 is a SEM micrograph showing the knee of a rat that 
was also injected with the same mixture of “as-made” glass 
microspheres and borosilicate glass particles that was used 
for the rat in FIG. 11, but was also injected with EDTA. As 
shown, all of the reacted microspheres were dissolved from 
the knee by the EDTA in FIG. 12 and only the irregularly- 
shaped borosilicate glass particles remain. This in vivo test 
thus confirmed the results of the in vitro test showing that the 
EDTA chelating agent is effective in dissolving the porous 
microspheres produced by glass/solution reaction within the 
body.
In view of the above, it will be seen that the several 
objects of the invention are achieved and other advantageous 
results attained.
As various changes could be made in the above methods 
without departing from the scope of the invention, it is 
intended that all matter contained in the above description or 
shown in the accompanying drawings shall be interpreted as 
illustrative and not in a limiting sense.
What is claimed is:
1. A method for preparing a shell or porous gel from glass 
particles which comprises the steps of:
(a) forming particles of an alkali borate glass composition 
containing one or more cations which react with an 
aqueous solution containing an anion reactive with said 
cation to form an aqueous insoluble material having a 
solubility limit of less than about 0.01 wt. %;
(b) immersing said glass composition particles in said 
aqueous solution to cause reaction of said particles to
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form said insoluble material which is essentially the 
same size as the as-made particles with the alkali and 
boron dissolving from the glass particles; and
(c) allowing said reaction to continue until said alkali and 
boron are substantially completely dissolved from said 
glass particles and the resulting product is composed of 
a shell filled with colloidal particles or gel, concentric 
shells or a porous, homogenous gel, said product being 
nonradioactive and not adapted for neutron irradiation.
2. A method as set forth in claim 1 wherein said alkali is 
lithium.
3. A method as set forth in claim 1 wherein said alkali is 
sodium.
4. A method as set forth in claim 1 wherein said alkali is 
potassium.
5. A method as set forth in claim 1 wherein said alkali is 
rubidium.
6. A method as set forth in claim 1 wherein said alkali is 
cesium.
7. A method as set forth in claim 1 wherein said alkali is 
constituted by a mixture of alkalis.
8. A method as set forth in claim 1 wherein said insoluble 
material is selected from the group consisting of oxides, 
hydroxides, phosphates, sulfates, chromates, carbonates and 
hydrated forms thereof.
9. A method as set forth in claim 8 wherein said insoluble 
material is an oxide.
10. Amethod as set forth in claim 8 wherein said insoluble 
material is a phosphate.
11. A method as set forth in claim 1 wherein said cation 
is selected from the group consisting of alkaline earth metal 
cations, transition metal cations, rare earth cations, alumi­
num and actinides.
12. Amethod as set forth in claim 11 wherein said alkaline 
earth metal cation is selected from the group consisting of 
magnesium, calcium, strontium and barium.
13. A method as set forth in claim 11 wherein said cation 
is aluminum.
14. A method as set forth in claim 11 wherein said cation 
is iron.
15. Amethod as set forth in claim 1 wherein said anion or 
ligand is selected from the group consisting of hydroxide, 
oxygen, phosphate, sulfate, chromate, carbonate and 
hydrated forms thereof.
16. A method as set forth in claim 15 wherein said anion 
is hydroxide.
17. A method as set forth in claim 15 wherein said anion 
is oxygen.
18. A method as set forth in claim 15 wherein said anion 
is phosphate.
19. A method as set forth in claim 1 wherein said product 
is in the form of microspheres, irregularly shaped particles 
or an assemblage of microspheres or irregularly shaped 
particles.
20. A method as set forth in claim 1 wherein said steps are 
carried out at a temperature below approximately 100° C.
21. A method as set forth in claim 20 wherein said 
temperature is room temperature or a temperature of 37V C.
22. A method as set forth in claim 1 wherein said product 
produced in step (c) is filled with a liquid, gas or solid 
material.
23. A method as set forth in claim 22 wherein said filler 
material is a chemotherapeutic drug.
24. A method as set forth in claim 1 wherein said product 
produced in step (c) is dried and heat treated at an elevated 
temperature.
25. Amethod as set forth in claim 24 wherein the resulting 

















26. A method as set forth in claim 24 wherein the resulting 
heat treated product is administered to a mammal as a bone 
growth or repair agent.
27. A method as set forth in claim 24 wherein said 
resulting heat treated product is added to a solution to 
remove therefrom a hazardous species selected from the 
group consisting of chromates, arsenates and uranates.
28. A method as set forth in claim 24 wherein said 
resulting heat treated product is impregnated internally or 
coated on its surface with catalytic material.
29. A method for administering a chemotherapeutic drug 
which comprises the steps of
(a) forming particles of an alkali borate glass composition 
containing a cation which reacts with an aqueous 
solution containing an anion reactive with said cation to 
form an aqueous insoluble material having a solubility 
limit of less than about 0.01 wt. %;
(b) immersing said glass composition particles in said 
aqueous solution to cause a reaction of said particles to 
form said insoluble material which is essentially the 
same size as the as-made particles with the alkali and 
boron dissolving from the glass particles;
(c) allowing said reaction to continue until said alkali and 
boron are substantially completely dissolved from said 
glass particles and the resulting product is composed of 
a shell filled with colloidal particles or gel, concentric 
shells or a porous, homogenous gel, said product being 
nonradioactive and not adapted for neutron irradiation;
(d) adding a chemotherapeutic drug to said product and 
administering the resulting product to a mammal; and
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(e) thereafter dissolving said insoluble material from said 
resulting product in vivo through the administration of 
a chelating agent.
30. A method as set forth in claim 29 wherein said 
chelating agent is ethylenediaminetetracetic acid.
31. A method as set forth in claim 29 wherein said alkali 
is lithium.
32. A method as set forth in claim 29 wherein said alkali 
is sodium.
33. A method as set forth in claim 29 wherein said alkali 
is potassium.
34. A method as set forth in claim 29 wherein said 
insoluble material is selected from the group consisting of 
oxides, hydroxides, phosphates, sulfates, chromates, carbon­
ates and hydrated forms thereof.
35. A method as set forth in claim 34 wherein said 
insoluble material is an oxide.
36. A method as set forth in claim 34 wherein said 
insoluble material is a phosphate.
37. A method as set forth in claim 29 wherein said product 
produced in step (c) is in the form of microspheres, irregu­
larly shaped particles or an assemblage of microspheres or 
irregularly shaped particles.
38. A method as set forth in claim 29 wherein said steps 
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